CTIC - CTI BioPharma Corp (NASDAQ) - Share Price and News. 0 6 12 18 CTIC Price; Jitta Line. Follow. Stock Summary. Jitta Ranking. Sorry, the data is not yet available for this stock. Jitta Ranking. CTI BioPharma Corp. (CTIC) has a Smart Score of 6 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. CTI BioPharma stock (symbol: CTIC) underwent a total of 5 stock splits. The most recent stock split occurred on January 3rd, One CTIC share bought prior. Stock price history for CTI BioPharma (CTIC). Highest end of day price In most cases it can be easily calculated by multiplying the share price with the.
Get CTi Biopharma Corp historical price data for CTIC stock. omolozhenielica.ru has all the historical stock data including the closing price, open, high, low. CTI Biopharma stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news. View today's CTi Biopharma Corp stock price and latest CTIC news and analysis. Create real-time notifications to follow any changes in the live stock price. The CTi Biopharma Corp stock price today is What Is the Stock Symbol for CTi Biopharma Corp? The stock ticker symbol for CTi Biopharma Corp is CTIC. Is. Webull offers Cti Biopharma (CTIC) historical stock prices, in-depth market analysis, NASDAQ: CTIC real-time stock quote data, in-depth charts. Get the latest CTI BioPharma Corp. (CTIC) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. CTI BioPharma Corp. (omolozhenielica.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock CTI BioPharma Corp. | Nyse: CTIC | Nyse. According to 6 analysts, the average rating for CTIC stock is "Buy." The month stock price forecast is $, which is an increase of % from the latest. Based on 7 Wall Street analysts offering 12 month price targets for CTI BioPharma in the last 3 months. The average price target is $ with a high forecast. Institutional Ownership and Shareholders. CTI BioPharma Corp (US:CTIC) has 0 institutional owners and shareholders that have filed 13D/G or 13F forms with the. Should you buy or sell CTi Biopharma Corp (CTIC)? Access our free stock analysis tools to chart, research and analyze CTi Biopharma Corp now!
CTIC - CTIC STOCK NEWS · Sobi completes acquisition of CTI BioPharma Corp. · Sobi successfully completes tender offer for all outstanding shares of common stock. Based on 7 Wall Street analysts offering 12 month price targets for CTI BioPharma in the last 3 months. The average price target is $ with a high forecast. A high-level overview of CTI BioPharma Corp. (CTIC) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and. The intrinsic value of one CTIC stock under the Base Case scenario is USD. Compared to the current market price of USD, CTI Biopharma Corp is. CTI BioPharma Corp. a biopharmaceutical company, develops, acquires, and commercializes oncology products for cancer treatment. Get the latest stock price for CTI BioPharma Corp. (CTIC:US), plus the latest news, recent trades, charting, insider activity, and analyst ratings. CTIC CTI BioPharma Corp. 6, $ $ (%). Today. Watchers, 6, Wk Low, $ Wk High, $ Market Cap, $B. Volume, M. CTI BioPharma Corp. (NASDAQ:CTIC) announced its quarterly earnings data on Monday, March, 6th. The biopharmaceutical company reported ($) earnings per share. Choose how much you'd like to invest in CTIC stock. Navigate to the Explore page. Then, type CTIC into the search bar. When you see CTIC stock appear in the.
Find the latest CTI BioPharma Corp. (omolozhenielica.ru) stock quote, history, news and other vital information to help you with your stock trading and investing. According to 6 analysts, the average rating for CTIC stock is "Buy." The month stock price forecast is $, which is an increase of % from the latest. The CTI Biopharma (CTIC) stock price and stock chart below provides intra-day data for the current/most recent trading day. CTI Biopharma reported $K in Stock for its fiscal quarter ending in December of Data for CTI Biopharma | CTIC - Stock including historical. Check if CTIC Stock has a Buy or Sell Evaluation. CTIC Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis and CTI BioPharma News.
A high-level overview of CTI BioPharma Corp. (CTIC) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and. CTI Biopharma stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news. CTI BioPharma Corp. (CTIC) has a Smart Score of 6 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Webull offers Cti Biopharma (CTIC) historical stock prices, in-depth market analysis, NASDAQ: CTIC real-time stock quote data, in-depth charts. CTIC - CTI BioPharma Corp (NASDAQ) - Share Price and News. Institutional Ownership and Shareholders. CTI BioPharma Corp (US:CTIC) has 0 institutional owners and shareholders that have filed 13D/G or 13F forms with the. Choose how much you'd like to invest in CTIC stock. Navigate to the Explore page. Then, type CTIC into the search bar. When you see CTIC stock appear in the. CTIC CTI BioPharma Corp. 6, $ $ (%). Today. Watchers, 6, Wk Low, $ Wk High, $ Market Cap, $B. Volume, M. Check if CTIC Stock has a Buy or Sell Evaluation. CTIC Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis and CTI BioPharma News. CTIC is defunct since June 30, Summary. CTI BioPharma Corp (CTIC) Share Price. Read detailed company share price. Find out more at Intelligent Investor. CTI Biopharma reported $K in Stock for its fiscal quarter ending in December of Data for CTI Biopharma | CTIC - Stock including historical. Ratings analysis incomplete due to data availability. Recommendations not provided. Maximize Income Goal. See Best High Dividend Stocks Model Portfolio for our. Get the latest CTI BioPharma Corp. (CTIC) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Get the latest stock price for CTI BioPharma Corp. (CTIC:US), plus the latest news, recent trades, charting, insider activity, and analyst ratings. CTIC - CTIC STOCK NEWS · Sobi completes acquisition of CTI BioPharma Corp. · Sobi successfully completes tender offer for all outstanding shares of common stock. Get CTi Biopharma Corp historical price data for CTIC stock. omolozhenielica.ru has all the historical stock data including the closing price, open, high, low. It's time for another dive into the biggest pre-market stock movers as we see what shares are on rising and falling on Tuesday! William White on InvestorPlace |. Historical daily share price chart and data for CTI BioPharma Corp. from to adjusted for splits and dividends. CTIC was delisted after June Stock price history for CTI BioPharma (CTIC). Highest end of day price In most cases it can be easily calculated by multiplying the share price with the. The intrinsic value of one CTIC stock under the Base Case scenario is USD. Compared to the current market price of USD, CTI Biopharma Corp is. The share price of CTI BioPharma Corp as of June 23, is $ / share. The Factor Analysis chart (below right) shows a view. The CTI Biopharma (CTIC) stock price and stock chart below provides intra-day data for the current/most recent trading day. Create and manipulate a CTI BIOPHARMA (NAQ:CTIC) stock price chart, with moving average, RSI & MACD overlays. Add your portfolio transactions. CTI BioPharma Corp. (NASDAQ:CTIC) released its quarterly earnings results on Monday, March, 6th. The biopharmaceutical company reported ($) earnings per. CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-. CTI BioPharma Corp. is a commercial biopharmaceutical company. It is focused on the acquisition, development and commercialization of targeted therapies for.
Alignment Medicare Advantage Reviews | How To Take Money Out Of Fidelity